Apotex Infringed Alcon's Eye Drop Patent: Judge
Following a bench trial, U.S. District Judge Richard L. Young determined that Alcon had proven the Apotex's generic equivalent of the company's topical ocular allergy medication infringed U.S. Patent Number 5,641,805. The judge further found Apotex had failed to prove the patent was invalid or unenforceable.
Switzerland-based Alcon, the largest eye care company in the world, and...
To view the full article, register now.